|
1
|
Ma T, Sun J, Zhao Z, Lei W, Chen Y, Wang
X, Yang J and Shen Z: A brief review: Adipose-derived stem cells
and their therapeutic potential in cardiovascular diseases. Stem
Cell Res Ther. 8:1242017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Marenberg ME, Risch N, Berkman LF,
Floderus B and de Faire U: Genetic susceptibility to death from
coronary heart disease in a study of twins. N Engl J Med.
330:1041–1046. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nora JJ, Lortscher RH, Spangler RD, Nora
AH and Kimberling WJ: Genetic-epidemiologic study of early-onset
ischemic heart disease. Circulation. 61:503–508. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Manting L, Haihong Z, Jing L, Shaodong C
and Yihua L: The model of rat lipid metabolism disorder induced by
chronic stress accompanying high-fat-diet. Lipids Health Dis.
10:1532011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ren K, Tang ZL, Jiang Y, Tan YM and Yi GH:
Apolipoprotein M. Clin Chim Acta. 446:21–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kappelle PJ, Ahnstrom J, Dikkeschei BD, de
Vries R, Sluiter WJ, Wolffenbuttel BH, van Tol A, Nielsen LB,
Dahlbäck B and Dullaart RP: Plasma apolipoprotein M responses to
statin and fibrate administration in type 2 diabetes mellitus.
Atherosclerosis. 213:247–250. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ye YZ, Cao B, Li MQ, Wang W, Wang RX, Rui
J, Wei LY, Jing ZH, Ji Y, Jiao GQ and Zou J: Dihydrotestosterone
regulating apolipoprotein M expression mediates via protein kinase
C in HepG2 cells. Lipids Health Dis. 11:1682012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Su W, Jiao G, Yang C and Ye Y: Evaluation
of apolipoprotein M as a biomarker of coronary artery disease. Clin
Biochem. 42:365–370. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wolfrum C, Poy MN and Stoffel M:
Apolipoprotein M is required for prebeta-HDL formation and
cholesterol efflux to HDL and protects against atherosclerosis. Nat
Med. 11:418–422. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Christoffersen C, Nielsen LB, Axler O,
Andersson A, Johnsen AH and Dahlback B: Isolation and
characterization of human apolipoprotein M-containing lipoproteins.
J Lipid Res. 47:1833–1843. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Endo A: A historical perspective on the
discovery of statins. Proc Jpn Acad Ser B Phys Biol Sci.
86:484–493. 2006. View Article : Google Scholar
|
|
12
|
Tsai NW, Lee LH, Huang CR, Chang WN, Chang
YT, Su YJ, Chiang YF, Wang HC, Cheng BC, Lin WC, et al: Statin
therapy reduces oxidized low density lipoprotein level, a risk
factor for stroke outcome. Crit Care. 18:R162014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Al-Ghoul WM, Kim MS, Fazal N, Azim AC and
Ali A: Evidence for simvastatin anti-inflammatory actions based on
quantitative analyses of NETosis and other inflammation/oxidation
markers. Results Immunol. 4:14–22. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schmidt M, Cannegieter SC, Johannesdottir
SA, Dekkers OM, Horváth-Puhó E and Sorensen HT: Statin use and
venous thromboembolism recurrence: A combined nationwide cohort and
nested case-control study. J Thromb Haemost. 12:1207–1215. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Paraskevaidis IA, Iliodromitis EK,
Ikonomidis I, Rallidis L, Hamodraka E, Parissis J, Andoniadis A,
Tzortzis S and Anastasiou-Nana M: The effect of acute
administration of statins on coronary microcirculation during the
pre-revascularization period in patients with myocardial
infraction. Atherosclerosis. 223:184–189. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang L and Zhao S: Effect of simvastatin
on the expression and regulation mechanism of apolipoprotein M. Int
J Mol Med. 29:510–514. 2012.PubMed/NCBI
|
|
17
|
Zhang X, Mao S, Luo G, Wei J,
Berggren-Söderlund M, Nilsson-Ehle P and Xu N: Effects of
simvastatin on apolipoprotein M in vivo and in vitro. Lipids Health
Dis. 10:1122011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ulven SM, Dalen KT, Gustafsson JA and Nebb
HI: LXR is crucial in lipid metabolism. Prostaglandins Leukot
Essent Fatty Acids. 73:59–63. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Y and Mangelsdorf DJ: LuXuRies of
lipid homeostasis: The unity of nuclear hormone receptors,
transcription regulation, and cholesterol sensing. Mol Interv.
2:78–87. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Houck KA, Borchert KM, Hepler CD, Thomas
JS, Bramlett KS, Michael LF and Burris TP: T0901317 is a dual
LXR/FXR agonist. Mol Genet Metab. 83:184–187. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wong J, Quinn CM and Brown AJ: Statins
inhibit synthesis of an oxysterol ligand for the liver × receptor
in human macrophages with consequences for cholesterol flux.
Arterioscler Thromb Vasc Biol. 24:2365–2371. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang X, Zhu Z, Luo G, Zheng L,
Nilsson-Ehle P and Xu N: Liver X receptor agonist downregulates
hepatic apoM expression in vivo and in vitro. Biochem Biophys Res
Commun. 371:114–117. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gervois P, Fruchart JC and Staels B: Drug
Insight: Mechanisms of action and therapeutic applications for
agonists of peroxisome proliferator-activated receptors. Nat Clin
Pract Endocrinol Metab. 3:145–156. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang Y, Lei W, Yan W, Li X, Wang X, Zhao
Z, Hui J, Shen Z and Yang J: microRNA-206 is involved in survival
of hypoxia preconditioned mesenchymal stem cells through targeting
Pim-1 kinase. Stem Cell Res Ther. 7:612016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang Z, Yang J, Yan W, Li Y, Shen Z and
Asahara T: Pretreatment of cardiac stem cells with exosomes derived
from mesenchymal stem cells enhances myocardial repair. J Am Heart
Assoc. 5:e0028562016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
You J, Sun J, Ma T, Yang Z, Wang X, Zhang
Z, Li J, Wang L, Ii M, Yang J and Shen Z: Curcumin induces
therapeutic angiogenesis in a diabetic mouse hindlimb ischemia
model via modulating the function of endothelial progenitor cells.
Stem Cell Res Ther. 8:1822017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Friesen JA and Rodwell VW: The
3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductases. Genome
Biol. 5:2482004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bonetti PO, Lerman LO, Napoli C and Lerman
A: Statin effects beyond lipid lowering-are they clinically
relevant? Eur Heart J. 24:225–248. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fichtlscherer S, Schmidt-Lucke C, Bojunga
S, Rössig L, Heeschen C, Dimmeler S and Zeiher AM: Differential
effects of short-term lipid lowering with ezetimibe and statins on
endothelial function in patients with CAD: Clinical evidence for
‘pleiotropic’ functions of statin therapy. Eur Heart J.
27:1182–1190. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cortellaro M, Cofrancesco E, Arbustini E,
Rossi F, Negri A, Tremoli E, Gabrielli L and Camera M: Atorvastatin
and thrombogenicity of the carotid atherosclerotic plaque: The
ATROCAP study. Thromb Haemost. 88:41–47. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Otto C, Geiss HC, Empen K and Parhofer KG:
Long-term reduction of C-reactive protein concentration by regular
LDL apheresis. Atherosclerosis. 174:151–156. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Luzak B, Boncler M, Rywaniak J, Wilk R,
Stanczyk L, Czyz M, Rysz J and Watala C: The effect of a platelet
cholesterol modulation on the acetylsalicylic acid-mediated blood
platelet inhibition in hypercholesterolemic patients. Eur J
Pharmacol. 658:91–97. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xu N and Dahlbäck B: A novel human
apolipoprotein (apoM). J Biol Chem. 274:31286–31290. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang XY, Dong X, Zheng L, Luo GH, Liu YH,
Ekström U, Nilsson-Ehle P, Ye Q and Xu N: Specific tissue
expression and cellular localization of human apolipoprotein M as
determined by in situ hybridization. Acta Histochem. 105:67–72.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Richter S, Shih DQ, Pearson ER, Wolfrum C,
Fajans SS, Hattersley AT and Stoffel M: Regulation of
apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear
factor-1alpha: Haploinsufficiency is associated with reduced serum
apolipoprotein M levels. Diabetes. 52:2989–2995. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Elsoe S, Christoffersen C, Luchoomun J,
Turner S and Nielsen LB: Apolipoprotein M promotes mobilization of
cellular cholesterol in vivo. Biochim Biophys Acta. 1831:1287–1292.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mulya A, Seo J, Brown AL, Gebre AK,
Boudyguina E, Shelness GS and Parks JS: Apolipoprotein M expression
increases the size of nascent pre beta HDL formed by ATP binding
cassette transporter A1. J Lipid Res. 51:514–524. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Christoffersen C, Jauhiainen M, Moser M,
Porse B, Ehnholm C, Boesl M, Dahlbäck B and Nielsen LB: Effect of
apolipoprotein M on high density lipoprotein metabolism and
atherosclerosis in low density lipoprotein receptor knock-out mice.
J Biol Chem. 283:1839–1847. 2008. View Article : Google Scholar : PubMed/NCBI
|
